Sun Pharma Q3 FY23 Gross Sales up 13.1%; Net profit up 5.2%
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Zidavi is recommended by the Infectious Disease Society of America
Diagnostic imaging will become an increasingly vital process in healthcare
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US
Krsnaa Diagnostics Limited has operationalized one diagnostics center at district hospital Male Akbarpur, Kanpur Dehat, Uttar Pradesh.
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022
Subscribe To Our Newsletter & Stay Updated